Funds Holding PDL Biopharma, Inc.

 
Stock Quotes for PDL Biopharma, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: High Yield
Sign-up for pdli investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: High Yield
Sign-up for pdli investment picks

 
News Articles for PDL Biopharma, Inc. top ^
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of purchasers of PDL BioPharma, Inc. (“PDL” or the “Company”) (NASDAQ: PDLI) securities between November 6, 2013 and September 16, 2014, inclusive (the “Class Period”) and informs investors who wish to become proactively involved in the litigation that they have until November 17, 2014 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In PDL BioPharma, Inc. To Contact Brower Piven Before The November 17, 2014 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma Bolsters Management Team investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1152338&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Inc. and Certain Officers - PDLI investment picks
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of investors who purchased PDL BioPharma Inc. (“PDL” or the “Company”) (Nasdaq:PDLI) common stock between November 6, 2013 and September 16, 2014.
Sign-up for SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action against PDL BioPharma Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 17, 2014 investment picks
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma to Announce Third Quarter 2014 Financial Results on November 10, 2014 investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of purchasers of PDL BioPharma, Inc. (“PDL” or the “Company”) (NASDAQ: PDLI) securities between November 6, 2013 and September 16, 2014, inclusive (the “Class Period”) and informs investors who wish to become proactively involved in the litigation that they have until November 17, 2014 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In PDL BioPharma, Inc. To Contact Brower Piven Before The November 17, 2014 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
Glancy Binkow & Goldberg LLP reminds investors of PDL BioPharma, Inc. (“PDL BioPharma” or the “Company”) (NASDAQ:PDLI) that those who purchased or otherwise acquired PDL BioPharma securities between November 6, 2013 and September 16, 2014, inclusive (the “Class Period”), have until November 17, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the District of Nevada.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against PDL BioPharma, Inc. investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Funds Holding PDL Biopharma, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding PDF Solutions, Inc.  |  Next: Funds Holding Pearson PLC